1245 studies found for:    "Alzheimer disease familial"
Show Display Options
Rank Status Study
21 Completed Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
Condition: Alzheimer's Disease
Intervention: Drug: Galantamine
22 Recruiting Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study.
Condition: Alzheimer Disease
Interventions: Other: High intensity aerobic exercise+strength;   Other: Low intensity aerobic exercise+strength
23 Recruiting A Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
24 Recruiting Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
25 Completed Alzheimer's Disease, Caregiving, and Social Networks
Condition: Alzheimer's Disease
Intervention:
26 Completed Development of NIC5-15 in the Treatment of Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia
Interventions: Drug: NIC5-15;   Drug: Placebo
27 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
28 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
29 Not yet recruiting Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Condition: Alzheimer Disease
Interventions: Drug: Cerebrolysin;   Drug: Donepezil
30 Recruiting A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: NIC5-15;   Drug: Placebo
31 Unknown  Far Infrared Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
32 Active, not recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
33 Completed Alzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
Interventions: Drug: Transdermal estradiol;   Drug: Medroxyprogesterone;   Drug: Placebo Patch;   Drug: Placebo
34 Completed
Has Results
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Galantamine 16 mg/day;   Drug: Galantamine 24 mg/day
35 Recruiting Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
36 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
37 Completed A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Galantamine hydrobromide
38 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)
39 Terminated
Has Results
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
40 Completed The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Neramexane

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years